References
- Levasseur SD, Wittenberg LA, White VA. Vitreoretinal lymphoma: a 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. JAMA Ophthalmol. 2013;131:50–55.
- Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the US. Cancer. 1988;62:2461–2465.
- Schabet M. Epidemiology of primary CNS lymphoma. J Neuro Oncol. 1999;43:199–201.
- Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist. 2011;16:1589–1599.
- Sagoo MS, Mehta H, Swampillai AJ, et al. Primary intraocular lymphoma. Surv Ophthalmol. 2014;59:503–516.
- Hoffman PM, McKelvie P, Hall AJ, et al. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye (Lond). 2003;17:513–521.
- Morgello S, Maiese K, Petito CK. T-cell lymphoma in the CNS: clinical and pathologic features. Neurology. 1989;39:1190–1196.
- Fritz APC, Jack A, Shanmugaratnam K, et al. International classification of diseases for oncology. 3rd ed. Geneva (Switzerland): World Health Organization; 2000. p. 61.
- Zablotska LB, Bogdanova TI, Ron E, et al. A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: dose-response analysis of thyroid follicular adenomas detected during first screening in Ukraine (1998–2000). Am J Epidemiol. 2008;167:305–312.
- Stepanova E, Karmaus W, Naboka M, et al. Exposure from the Chernobyl accident had adverse effects on erythrocytes, leukocytes, and, platelets in children in the Narodichesky region, Ukraine: a 6-year follow-up study. Environ Health. 2008;7:21.
- Zablotska LB, Bazyka D, Lubin JH, et al. Radiation and the risk of chronic lymphocytic and other leukemias among chornobyl cleanup workers. Environ Health Perspect. 2013;121:59–65.
- Fedirko P. Eye diseases among liquidators: lesions of fundus and macula, vitreous and lens. Paper presented at: PSR/IPPNW-Congress “Gesundheit der Liquidatoren”; 2005 Nov 12; Bern; 2006.
- Chaiter Y, Brenner B, Aghai E, et al. High incidence of myeloproliferative disorders in Ashkenazi Jews in northern Israel. Leuk Lymphoma. 1992;7:251–255.
- Moslehi R, Devesa SS, Schairer C, et al. Rapidly increasing incidence of ocular non-Hodgkin lymphoma. J Natl Cancer Inst. 2006;98:936–939.
- Moslehi R, Coles FB, Schymura MJ. Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin’s lymphoma. Expert Rev Ophthalmol. 2011;6:175–180.
- Moslehi R, Schymura MJ, Nayak S, et al. Ocular adnexal non-Hodgkin’s lymphoma: a review of epidemiology and risk factors. Expert Rev Ophthalmol. 2011;6:181–193.